Yew Bio-Pharm Group, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was USD 14.843 million compared to USD 9.562 million a year ago. Operating loss was USD 430,641 compared to operating Income of USD 856,500 a year ago. Net loss was USD 544,777 compared to net income of USD 737,567 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to basic earnings per share from continuing operations of USD 0.01 a year ago. For the half year, total revenue was USD 23.580 million compared to USD 11.591 million a year ago. Operating income was USD 2.536 million compared to USD 1.013 million a year ago. Net income was USD 2.373 million compared to USD 888,979 a year ago. Basic earnings per share from continuing operations was USD 0.05 compared to USD 0.02 a year ago.